上海迪赛诺化学制药有限公司
Shanghai Desano Chemical Pharmaceutical Co. Ltd.
Country: CN CDE+DMF+CEP VERY_HIGH
🇨🇳 CDE
32
35 products shown
🇺🇸 DMF
34
34 products shown
🇪🇺 CEP
10
10 products shown
Total
76
registrations
🇨🇳 CDE 注册 (35)
| Product | CAS | Status | Reg Number |
|---|---|---|---|
| Abacavir 硫酸阿巴卡韦 | 136470-78-5 | Class A | Y20220000956 |
| Avatrombopag 马来酸阿伐曲泊帕 | 570406-98-3 | Class A | Y20220000491 |
| Brivaracetam 布瓦西坦 | 357336-20-0 | Class A | Y20240000746 |
| Brivaracetam 布瓦西坦 | 357336-20-0 | Class I | Y20210000145 |
| Crisaborole 克立硼罗 | 906673-24-3 | Class A | Y20220001304 |
| Dolutegravir Sodium 多替拉韦钠 | 1051375-16-6 | Class A | Y20240000231 |
| Dotinurad 多替诺雷 | 1285572-51-1 | Class I | Y20250001101 |
| Edoxaban Tosylate 甲苯磺酸艾多沙班 | 480449-70-5 | Class A | Y20210000342 |
| Efavirenz 依非韦伦 | 154598-52-4 | Class A | Y20190008867 |
| Eltrombopag Olamine 艾曲泊帕乙醇胺 | 496775-61-2 | Class A | Y20210000799 |
| Emtricitabine 恩曲他滨 | 143491-57-0 | Class A | Y20170002214 |
| Finerenone HS236 | 1050477-31-0 | Class I | Y20250000403 |
| Isavuconazole 硫酸艾沙康唑 | 241479-67-4 | Class A | Y20230001386 |
| Lamivudine 拉米夫定 | 134678-17-4 | Class A | Y20190009905 |
| Lamivudine 拉米夫定 | 134678-17-4 | Class A | Y20170001950 |
| Lasmiditan 半琥珀酸拉米地坦 | 439239-90-4 | Class I | Y20240000796 |
| Letermovir 来特莫韦 | 917389-32-3 | Class A | Y20240000784 |
| Linezolid 利奈唑胺 | 165800-03-3 | Class A | Y20170001525 |
| Lopinavir And Ritonavir 洛匹那韦 | 369372-47-4 | Class A | Y20200000131 |
| Nevirapine 奈韦拉平 | 129618-40-2 | Class A | Y20190008445 |
| Olmesartan Medoxomil, Process II 奥美沙坦酯 | 144689-63-4 | Class I | Y20260000262 |
| Omadacycline 甲苯磺酸奥马环素 | 389139-89-3 | Class I | Y20260000013 |
| Omadacycline 甲苯磺酸奥马环素 | 389139-89-3 | Class I | Y20250000850 |
| Oseltamivir 磷酸奥司他韦 | 196618-13-0 | Class A | Y20210000082 |
| Rilpivirine 盐酸利匹韦林 | 500287-72-9 | Class A | Y20230001024 |
| Ritonavir 利托那韦 | 155213-67-5 | Class A | Y20190009796 |
| Roxadustat 罗沙司他 | 808118-40-3 | Class A | Y20230000947 |
| Stavudine 司他夫定 | 3056-17-5 | Class A | Y20190001500 |
| Tedizolid 磷酸特地唑胺 | 856866-72-3 | Class A | Y20210000380 |
| Tenofovir Alafenamide 富马酸丙酚替诺福韦 | 379270-37-8 | Class A | Y20180001168 |
| Tenofovir Disoproxil 酒石酸替诺福韦二吡呋酯 | 201341-05-1 | Class A | Y20170001376 |
| Upadacitinib 乌帕替尼 | 1310726-60-3 | Class I | Y20250001177 |
| Valaciclovir 盐酸伐昔洛韦 | 124832-26-4 | Class A | Y20190008119 |
| Vericiguat 维立西呱 | 1350653-20-1 | Class I | Y20260000568 |
| Zidovudine 齐多夫定 | 30516-87-1 | Class A | Y20190008444 |
🇺🇸 DMF 注册 (34)
| Product | CAS | DMF Number | Date |
|---|---|---|---|
| 2,5-pyridinedicarboxylic Acid,1-(2,2-dimethoxyethyl)-1,4-dihydro-3-methoxy-4-oxo-, 2-methyl Ester | - | 34984 | 2020-06-28 |
| Atazanavir Sulfate 硫酸阿扎那韦 | 198904-31-3 | 26672 | 2012-11-20 |
| Atovaquone 阿托伐醌 | 95233-18-4 | 43622 | 2026-02-12 |
| Cabotegravir Sodium 卡替拉韦钠 | 1051375-10-0 | 37452 | 2022-09-14 |
| Canagliflozin 卡格列净 | 842133-18-0 | 30366 | 2015-12-31 |
| Dolutegravir Sodium 多替拉韦钠 | 1051375-16-6 | 30365 | 2016-02-03 |
| Dotinurad 多替诺雷 | 1285572-51-1 | 43344 | 2025-12-24 |
| Edoxaban Tosylate Monohydrate 甲苯磺酸艾多沙班 | 1229194-11-9 | 36062 | 2021-07-09 |
| Efavirenz USP 依非韦伦 | 154598-52-4 | 23271 | 2009-11-04 |
| Elagolix Sodium 艾拉戈克钠 | 834153-87-6 | 36823 | 2022-03-09 |
| Eltrombopag Olamine 艾曲泊帕乙醇胺 | 496775-61-2 | 41910 | 2025-06-16 |
| Elvitegravir | 697761-98-1 | 32456 | 2017-12-20 |
| Emtricitabine 恩曲他滨 | 143491-57-0 | 25617 | 2011-12-19 |
| Isavuconazonium Sulfate | 946075-13-4 | 40324 | 2024-08-27 |
| Lamivudine USP 拉米夫定 | 134678-17-4 | 21278 | 2008-01-22 |
| Lasmiditan Hemisuccinate 拉米地坦 | 439239-92-6 | 40059 | 2024-09-05 |
| Letermovir 来特莫韦 | 917389-32-3 | 40787 | 2024-11-22 |
| Lopinavir 洛匹那韦 | 192725-17-0 | 30154 | 2015-12-08 |
| Lopinavir Hydrate 洛匹那韦 | 1239071-09-0 | 34144 | 2019-09-16 |
| Lumefantrine 本芴醇 | 82186-77-4 | 40658 | 2024-12-30 |
| Mefloquine Hydrochloride 盐酸甲氟喹 | 51773-92-3 | 26883 | 2013-02-06 |
| Nevirapine USP 奈韦拉平 | 129618-40-2 | 21280 | 2008-01-22 |
| Omadacycline Tosylate 甲苯磺酸奥马环素 | 1075240-43-5 | 43248 | 2025-12-19 |
| Oseltamivir Phosphate 磷酸奥司他韦 | 204255-11-8 | 35514 | 2021-01-15 |
| Praziquantel 吡喹酮 | 55268-74-1 | 26837 | 2013-01-14 |
| Rilpivirine Hydrochloride 盐酸利匹韦林 | 700361-47-3 | 39552 | 2024-02-27 |
| Ritonavir USP 利托那韦 | 155213-67-5 | 24383 | 2010-12-02 |
| Rosuvastatin Calcium 瑞舒伐他汀钙 | 287714-41-4 | 27777 | 2013-09-06 |
| Stavudine USP 司他夫定 | 3056-17-5 | 21279 | 2008-01-22 |
| Tedizolid Phosphate 磷酸特地唑胺 | 856867-55-5 | 40498 | 2024-10-11 |
| Tenofovir 替诺福韦 | 147127-20-6 | 26767 | 2012-12-07 |
| Tenofovir Alafenamide Fumarate 富马酸丙酚替诺福韦 | 1392275-56-7 | 31700 | 2017-03-31 |
| Tenofovir Disoproxil Fumarate 酒石酸替诺福韦二吡呋酯 | 201341-05-1 | 25304 | 2011-09-13 |
| Zidovudine USP 齐多夫定 | 30516-87-1 | 21277 | 2008-01-22 |
🇪🇺 CEP 注册 (10)
| Product | CAS | CEP Number | Date |
|---|---|---|---|
| Abacavir Sulfate 硫酸阿巴卡韦 | 188062-50-2 | CEP 2021-179 - Rev 00 | 2023-12-06 |
| Atazanavir Sulfate 硫酸阿扎那韦 | 198904-31-3 | R0-CEP 2021-115 - Rev 00 | 2023-08-25 |
| Lamivudine 拉米夫定 | 134678-17-4 | CEP 2015-272 - Rev 01 | 2024-06-17 |
| Lamivudine, Process C 拉米夫定 | 134678-17-4 | R0-CEP 2023-119 - Rev 00 | 2023-06-30 |
| Nevirapine 奈韦拉平 | 129618-40-2 | R0-CEP 2020-267 - Rev 00 | 2022-12-12 |
| Praziquantel 吡喹酮 | 55268-74-1 | R1-CEP 2014-144 - Rev 01 | 2021-12-07 |
| Raltegravir Potassium 钾拉替拉韦 | 871038-72-1 | CEP 2023-329 - Rev 00 | 2024-12-02 |
| Ritonavir 利托那韦 | 155213-67-5 | CEP 2017-229 - Rev 03 | 2024-09-03 |
| Ritonavir, Form-ii 利托那韦 | 155213-67-5 | R0-CEP 2020-416 - Rev 00 | 2021-05-12 |
| Zidovudine 齐多夫定 | 30516-87-1 | R0-CEP 2021-015 - Rev 00 | 2022-07-13 |
Source: cde+fda_direct; DMF高置信 | Updated: 2026-09-11 06:00:12